MIRM
Medium convictionMirum Pharmaceuticals, Inc.
Healthcare · NASDAQ
$5.1B mkt cap
Brief updated Jun 16, 2026
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholesta
Mirum Pharmaceuticals driven by risk-on rotation
Mirum Pharmaceuticals is a biopharmaceutical firm developing treatments for rare conditions, with 735.0% year-over-year revenue growth. The company's conviction score is 53 out of 100, indicating moderate confidence. Analysts have a buy consensus rating, despite a negative price-to-earnings ratio of -7.6x. This setup is interesting due to the contrast between strong revenue growth and poor margins, including a gross margin of 8136.0% and a net margin of -14024.0%
Why now
The current risk-on rotation underway makes this the right moment to pay attention to Mirum Pharmaceuticals, as it is a direct beneficiary of this market force. With a recent macro signal indicating a +20 driver, the company's stock may be poised for movement
Key risks
Valuation risk is a major concern, as the company's DCF intrinsic value is -$3449, indicating potential overvaluation. Execution risk is also a factor, as the company's lead experimental drug, LIVMARLI, is still undergoing trials. Additionally, the company's poor margins, including a net margin of -14024.0%, pose a significant risk to its long-term viability
What to watch
Over the next quarter, watch for updates on LIVMARLI's trial progress and the company's ability to improve its margins. Additionally, monitor the company's revenue growth and analyst consensus rating, as any changes to these metrics could significantly impact the stock's performance
Trump Tried To Stop It—Now A $4.7 Billion US-Canada Bridge Is About To Open: Report
A new $4.7 billion US-Canada bridge is set to open, which could increase trade and economic activity between the two countries, despite previous attempts by Trump to stop it. This development may have implications for the trade relationship and economic growth in the region.
Jun 9, 2026
Goldman Sachs sends strong message on next Fed rate cut
Goldman Sachs has sent a strong message regarding the next Federal Reserve rate cut, potentially influencing market expectations and monetary policy decisions. This guidance could impact interest rates and the overall economic outlook.
Jun 9, 2026
GE Aerospace (GE) Anticipates More China Deals Following Trump-Xi Summit
The anticipated increase in deals between GE Aerospace and China following the Trump-Xi summit indicates a potential easing of geopolitical tensions, which could positively impact trade and economic relations between the US and China.
Jun 9, 2026
Deere Tariff Relief Reshapes Costs Margins And Competitive Standing
Deere is experiencing tariff relief, which is expected to reshape its costs, margins, and competitive standing in the market. This change in tariff policy could have broader implications for the industry and trade dynamics.
Jun 10, 2026
Earnings surprises
-3257.5%
2026-05
-650.0%
2026-02
+150.0%
2025-11
+61.3%
2025-08
+23.1%
2025-05
The US has held off on striking Iran, leading to a gain in cryptocurrency prices, with analysts seeing a potential 'strong and vital move' in Bitcoin if the situation continues to de-escalate. This de-escalation could reduce geopolitical risk and increase investor appetite for riskier assets like cryptocurrencies.
Wall Street giants such as Goldman Sachs and BlackRock have endorsed the CLARITY Act, which aims to provide regulatory clarity for cryptocurrencies, potentially paving the way for increased institutional investment and adoption. This development could have significant implications for the crypto market and the broader financial sector.
The Federal Reserve has decided to keep its key interest rate unchanged, leading to a partial recovery in the stock market. This decision has significant implications for the overall monetary policy and market expectations.
The equities market is experiencing intraday losses ahead of the highly anticipated Federal Reserve decision, which could significantly impact market direction and investor sentiment. The decision, coupled with major tech earnings reports, is poised to influence the overall economic outlook.
Risk appetite returns to the market despite geopolitical tensions, with Bitcoin holding firm, indicating a potential decrease in geopolitical risk. This shift in market sentiment could impact various asset classes and the overall macro environment.
Generated Tue, 16 Jun 2026 05:00:29 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.